Sepsis Research - Septicemia, Diagnosis, Symptoms, Treatment

Sepsis Research Today is a free monthly online journal that collates and summarizes the latest research about Sepsis, including details on septicemia, diagnosis, symptoms, treatment.


Sepsis Research Today

Home

View Latest Issue

Information About Sepsis

Books on Sepsis

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 1 (January)

  1. Saving infected catheters: why and how.
    Blood Purif, 23(1): 23-8. [Abstract] [Full-text]
  2. Protective effect of dextromethorphan against endotoxic shock in mice.
    Biochem Pharmacol, 69(2): 233-40. [Abstract] [Full-text]
  3. Lactobacillus sepsis associated with probiotic therapy.
    Pediatrics, 115(1): 178-81. [Abstract] [Full-text]
  4. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Peptides, 26(2): 207-16. [Abstract] [Full-text]
  5. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Peptides, 26(2): 169-75. [Abstract] [Full-text]
  6. Cowpox virus infection associated with a streptococcal septicaemia in a foal.
    J Comp Pathol, 132(1): 101-5. [Abstract] [Full-text]
  7. Protective role of angiopoietin-1 in endotoxic shock.
    Circulation, 111(1): 97-105. [Abstract] [Full-text]
  8. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia.
    Pediatrics, 115(1): e15-9. [Abstract] [Full-text]
  9. Release of tumour necrosis factor alpha (TNFalpha) by TNFalpha cleaving enzyme (TACE) in response to septic stimuli in vitro.
    Br J Anaesth, 94(2): 222-8. [Abstract] [Full-text]
  10. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
    J Infect Dis, 191(3): 422-34. [Abstract] [Full-text]
  11. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
    J Infect Dis, 191(3): 348-57. [Abstract] [Full-text]
  12. Molecular mechanisms involved in the pathogenesis of septic shock.
    Arch Med Res, 35(6): 465-79. [Abstract] [Full-text]
  13. Bacteremia among children admitted to a rural hospital in Kenya.
    N Engl J Med, 352(1): 39-47. [Abstract] [Full-text]
  14. Effect of inoculum size on detection of Candida growth by the BACTEC 9240 automated blood culture system using aerobic and anaerobic media.
    J Clin Microbiol, 43(1): 433-5. [Abstract] [Full-text]
  15. Methicillin-resistant Staphylococcus caprae in a neonatal intensive care unit.
    J Clin Microbiol, 43(1): 363-7. [Abstract] [Full-text]
  16. Extensive gene diversity in septicemic Escherichia coli strains.
    J Clin Microbiol, 43(1): 66-73. [Abstract] [Full-text]
  17. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
    J Antimicrob Chemother, 55(1): 90-4. [Abstract] [Full-text]
  18. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    J Antimicrob Chemother, 55(1): 45-50. [Abstract] [Full-text]
  19. Plastic surgery management in pediatric meningococcal-induced purpura fulminans.
    Clin Plast Surg, 32(1): 117-21, ix. [Abstract] [Full-text]
  20. Early application of generic mortality risk scores in presumed meningococcal disease.
    Pediatr Crit Care Med, 6(1): 9-13. [Abstract] [Full-text]
  21. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.
    Pediatr Crit Care Med, 6(1): 2-8. [Abstract] [Full-text]
  22. Amino acid metabolism in leg muscle after an endotoxin injection in healthy volunteers.
    Am J Physiol Endocrinol Metab, 288(2): E360-4. [Abstract] [Full-text]
  23. Septic shock.
    Lancet, 365(9453): 63-78. [Abstract] [Full-text]
  24. Preliminary investigation of bacteremia incidence after removal of the Haas palatal expander.
    Am J Orthod Dentofacial Orthop, 127(1): 64-6. [Abstract] [Full-text]
  25. Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats.
    Pediatr Surg Int, 21(1): 20-4. [Abstract] [Full-text]
  26. Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.
    Anaesthesia, 60(2): 155-62. [Abstract] [Full-text]
  27. TNFalpha mediates sepsis-induced impairment of basal and leucine-stimulated signaling via S6K1 and eIF4E in cardiac muscle.
    J Cell Biochem, 94(2): 419-31. [Abstract] [Full-text]
  28. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.
    J Virol, 79(3): 1686-700. [Abstract] [Full-text]
  29. Activity of the new quinolone WCK 771 against pneumococci.
    Clin Microbiol Infect, 11(1): 9-14. [Abstract] [Full-text]
  30. Characterization of membrane N-glycan binding sites of lysozyme for cardiac depression in sepsis.
    Intensive Care Med, 31(1): 129-37. [Abstract] [Full-text]
  31. Post-ICU mortality in critically ill infected patients: an international study.
    Intensive Care Med, 31(1): 56-63. [Abstract] [Full-text]
  32. Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke.
    J Appl Physiol, 98(2): 697-705. [Abstract] [Full-text]
  33. Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock.
    Am J Physiol Heart Circ Physiol, 288(2): H577-83. [Abstract] [Full-text]
  34. Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition.
    Intensive Care Med, 30(12): 2271-8. [Abstract] [Full-text]
  35. Sickness behavior of rats with abdominal sepsis can be improved by antibiotic and G-CSF prophylaxis in clinic modeling randomized trials.
    Inflamm Res, 53(12): 697-705. [Abstract] [Full-text]
  36. Inclusion criteria for clinical trials in sepsis: did the American College of Chest Physicians/Society of Critical Care Medicine consensus conference definitions of sepsis have an impact?
    Chest, 127(1): 242-5. [Abstract] [Full-text]
  37. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    Am J Ophthalmol, 139(1): 135-40. [Abstract] [Full-text]
  38. Octreotide ameliorates sepsis-induced pelvic inflammation in female rats by a neutrophil-dependent mechanism.
    Peptides, 26(3): 493-9. [Abstract] [Full-text]
  39. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis.
    Cytokine, 29(4): 169-75. [Abstract] [Full-text]
  40. Delayed viremia and antibody responses in Puumala hantavirus challenged passively immunized cynomolgus macaques.
    Arch Virol, 150(1): 79-92. [Abstract] [Full-text]
  41. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
    J Infect Dis, 191(4): 588-95. [Abstract] [Full-text]
  42. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations.
    J Infect Dis, 191(4): 554-61. [Abstract] [Full-text]
  43. Rectal duplication cyst presenting as perianal sepsis: report of two cases and review of the literature.
    Dis Colon Rectum, 47(12): 2208-10. [Abstract] [Full-text]
  44. Hematogenous infection of the human temporomandibular joint.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 99(2): E11-7. [Abstract] [Full-text]
  45. A survey of dental care protocols among US organ transplant centers.
    Clin Transplant, 19(1): 15-8. [Abstract] [Full-text]
  46. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.
    Eur J Clin Microbiol Infect Dis, 24(1): 23-30. [Abstract] [Full-text]
  47. Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication.
    Eur J Clin Microbiol Infect Dis, 24(1): 61-4. [Abstract] [Full-text]
  48. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.
    Eur J Clin Microbiol Infect Dis, 24(1): 31-40. [Abstract] [Full-text]
  49. Value of anaerobic blood cultures in pediatrics.
    Eur J Clin Microbiol Infect Dis, 24(1): 47-50. [Abstract] [Full-text]
  50. Therapeutic intervention and targets for sepsis.
    Annu Rev Med, 56: 225-48. [Abstract] [Full-text]
  51. Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.
    AIDS Res Hum Retroviruses, 21(1): 13-6. [Abstract] [Full-text]
  52. Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
    Int J Antimicrob Agents, 25(2): 168-72. [Abstract] [Full-text]
  53. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
    Int J Antimicrob Agents, 25(2): 163-7. [Abstract] [Full-text]
  54. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.
    J Hepatol, 42(2): 195-201. [Abstract] [Full-text]
  55. A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome.
    Ther Apher Dial, 8(6): 503-6. [Abstract] [Full-text]
  56. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey.
    BJOG, 112(1): 89-96. [Abstract] [Full-text]
  57. Interaction between dexamethasone treatment and the corticotropin stimulation test in septic shock.
    Ann Pharmacother, 39(2): 335-8. [Abstract] [Full-text]
  58. Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis.
    Ann Pharmacother, 39(2): 262-7. [Abstract] [Full-text]
  59. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
    Antimicrob Agents Chemother, 49(2): 760-6. [Abstract] [Full-text]
  60. Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.
    Antimicrob Agents Chemother, 49(2): 650-5. [Abstract] [Full-text]
  61. The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?
    J Physiol, 562: 647-53. [Abstract] [Full-text]
  62. Microdialysis for measurement of hepatic and systemic nitric oxide biosynthesis in septic rats.
    Acta Anaesthesiol Scand, 49(1): 28-34. [Abstract] [Full-text]
  63. Development of a time-to-positivity assay as a tool in the antibiotic management of septic patients.
    Clin Microbiol Infect, 11(2): 109-14. [Abstract] [Full-text]
  64. Asymptomatic carotid atherosclerosis is associated with circulating chlamydia pneumoniae DNA in younger normotensive subjects in a general population survey.
    Arterioscler Thromb Vasc Biol, 25(2): 386-91. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Sepsis Research Today. All Rights Reserved.



Sepsis Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



Sepsis Books

Novel Therapeutic Strategies in the Treatment of Sepsis (Infectious Disease and Therapy)

Novel Therapeutic Strategies in the Treatment of Sepsis (Infectious Disease and Therapy)